Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance
title

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits

 

escrs app advert yo advert

Posters

Search Title by author or title

Visual outcomes following implantation of a trifocal lens

Poster Details

First Author: L. Paparo COLOMBIA

Co Author(s):                        

Abstract Details

Purpose:

To assess visual outcomes following bilateral implantation of a trifocal intraocular lens (IOL)

Setting:

Cornea and Refractive Surgery Service, VISUALASER, Centro Medio Imbanaco. Cali, Colombia

Methods:

This ongoing, prospective, single center study included 20 patients bilaterally implanted with the FineVision IOL (PhysIOL SA, Liège, Belgium) with a mean power of 20.20 ± 1.95. Cataract surgery was performed using a standardized suture-less technique. Monocular uncorrected and corrected visual acuities (VA) at near, intermediate and distance were assessed up to 6 months postoperative. Binocular defocus curve measurements were performed by recording best corrected visual acuity through lenses from -3.0 D to +4.0 D in 0.5 D steps.

Results:

The preoperative Visual acuities were: Uncorrected distance visual acuities (UCDVA):0.49 logMar, Best distance corrected visual acuities (BDCVA):0.08 logMar Data for the first 18 patients showed that at 4 months postoperative, mean monocular uncorrected VA (n=18) was 0.0878 ± 0.1072. Mean monocular uncorrected intermediate VA (IVA) was 0.2 ± 0.086 and mean monocular near VA (NVA) was 0.115 ± 0.1263. Mean monocular best distance corrected (BDC) VA was 0.0378 ± 0.0792, mean monocular BDCIVA was 0.1888 ± 0.079 and mean monocular BCDNVA was 0.0778 ± 0.083. Mean sphere was 0.0769 ± 0.270. The defocus curve showed that the IOL provided continuous range of vision.

Conclusions:

The FineVision trifocal IOL demonstrated good visual acuity at near, intermediate and distance. Contrast sensitivity, quality of life data will be collected and reported at the 6 month postoperative visit.

Financial Disclosure:

NONE

Back to Poster listing